J Physiol Boston Smyposia
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 586, Number 18, 4393-4400, September 15, 2008 DOI: 10.1113/jphysiol.2008.156729
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
586/18/4393    most recent
jphysiol.2008.156729v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Weber, A. J.
Right arrow Articles by Viswanathan, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, A. J.
Right arrow Articles by Viswanathan, S.
Related Collections
Right arrow Review articles
Right arrow Neuroscience

SYMPOSIUM REPORT

Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina

A. J. Weber1,2, C. D. Harman1 and S. Viswanathan3

1 Department of Physiology
2 The Neuroscience Program, Michigan State University, East Lansing, MI, USA
3 Indiana University School of Optometry, Bloomington, IN, USA

Glaucoma is an optic neuropathy that originates with pressure-induced damage to the optic nerve. This results in the retrograde degeneration of ganglion cells in the retina, and a progressive loss of vision. Over the past several years, a number of studies have described the structural and functional changes that characterize ganglion cell degeneration in the glaucomatous eye, and following optic nerve injury. In addition, a variety of different strategies for providing neuroprotection to the injured retina have been proposed. Many of these are based on the use of brain-derived neurotrophic factor (BDNF), a particularly potent neuroprotectant in the mammalian eye and the basis of our research in this area. Of particular importance is the fact that BDNF not only promotes ganglion cell survival following damage to the optic nerve, but also helps to preserve the structural integrity of the surviving neurons, which in turn results in enhanced visual function. The studies presented here describe these attributes, and serve as the foundation for ongoing work that suggests a need to think beyond the eye in the development of future treatment strategies.

(Received 12 May 2008; accepted after revision 16 June 2008; first published online 19 June 2008)
Corresponding author A. J. Weber: Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.  Email: weberar{at}msu.edu


This report was presented at The Journal of Physiology Symposium on Retinal ganglion cells in model organisms: development, function and disease, which took place in Fort Lauderdale, FL, USA, 26 April 2008. It was commissioned by the Editorial Board and reflects the views of the authors.




This article has been cited by other articles:


Home page
J. Physiol.Home page
Z. J. Zhou and M. A. McCall
Retinal ganglion cells in model organisms: development, function and disease
J. Physiol., September 15, 2008; 586(18): 4343 - 4345.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 The Physiological Society.